PRA023 Decreases Bowel Urgency, Movement in Patients with Ulcerative Colitis
Findings were presented in an abstract at ACG 2023, highlighting the importance of addressing bowel urgency in patients with ulcerative colitis.
Source: hcplive.com
Page 19 - Phase 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phase 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phase 2 Today - Breaking & Trending Today
Mirikizumab Sustains CDAI, PRO Remission for Crohn Disease, Shown in Phase 2 Data at ACG 2023
Results from the 104-week extension study were presented at ACG 2023, demonstrating mirikizumab’s favorable safety and efficacy profiles.
Source: hcplive.com
Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B
Roche has agreed to acquire Telavant Holdings, maker of an inflammatory bowel disease drug, from Roivant Sciences and Pfizer for $7.25 billion.
Source: beckershospitalreview.com
Apraglutide Reduces Parenteral Support Dependency in Patients with SBS-IF, CIC
Final data from STARS Nutrition were presented at United European Gastroenterology Week 2023, demonstrating a significant reduction in parenteral support.
Source: hcplive.com
Synaptogenix trial - 'extremely important' outcome for Alzheimer's
Patients with severe Alzheimer's Disease (AD) showed no cognitive decline throughout a ten-month trial while being treated with Bryostatin-1.
Source: outsourcing-pharma.com